Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials

Figure 4

Response rate, PFS, OS of Bevacizumab versus other targeted drugs in EGFR untested NSCLC patients.

Figure 4

doi: https://doi.org/10.1371/journal.pone.0062038.g004